v3.21.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 31,156,747 $ 10,931,890
Short-term investments 100,899,984 100,842,438
Accounts receivable 103,232 177,239
Prepaid expenses and other current assets 1,718,364 1,842,620
Total Current Assets 133,878,327 113,794,187
Property and Equipment, net 967,582 676,262
Other Assets    
In-process R&D 5,866,000 5,866,000
Goodwill 1,452,338 1,452,338
Operating lease right-of-use asset 1,947,192 2,035,882
Finance lease right-of-use asset 217,469 247,194
Deposits 141,201 122,779
Total Other Assets 9,624,200 9,724,193
Total Assets 144,470,109 124,194,642
Current Liabilities    
Accounts payable 792,545 1,051,764
Deferred revenue, current portion 93,529 603,717
Operating lease liability, current portion 285,927 278,753
Finance lease liability, current portion 109,757 108,127
Accrued expenses and other liabilities 1,764,385 1,614,534
Total Current Liabilities 3,046,143 3,656,895
Long Term Liabilities    
Other long-term liabilities 43,754 36,243
Derivative warrant liability 42,481 33,779
Deferred tax liability 361,911 361,911
Deferred revenue, net of current portion 237,500 237,500
Operating lease liability, net of current portion 1,227,634 1,301,636
Financing lease liability, net of current portion 132,181 160,240
Contingent consideration, net of current portion 2,255,480 2,250,844
Contingent consideration, related party - net of current portion 663,035 661,671
Total Liabilities 8,010,119 8,700,719
Commitments and Contingencies
Stockholders' Equity    
Common stock, $.0002 par value; 250,000,000 and 250,000,000 shares authorized, 25,137,410 and 22,592,500 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 5,027 4,519
Additional paid-in capital 275,618,780 247,048,349
Accumulated deficit (138,179,663) (130,647,485)
Accumulated other comprehensive loss (147,788) (166,056)
Total Stockholders' Equity - Heat Biologics, Inc. 137,296,356 116,239,327
Non-Controlling Interest (836,366) (745,404)
Total Stockholders' Equity 136,459,990 115,493,923
Total Liabilities and Stockholders' Equity $ 144,470,109 $ 124,194,642

Source